docetaxel,sotorasib
aventis,amgen,sanofi
['nsclc', 'sotorasib', 'docetaxel', 'sclc']
improvements in progression free survival with kras inhibitor sotorasib over docetaxel in difficult to treat krasg12c nsclc patients. #esmo22 listen to the future of social media. 
Scientist, New Yorker, Weill Cornell Medical Center. Cancer Biologist, Lung and Breast cancer basic and translational research. Views are my own.